Seres Therapeutics, Inc. earnings per share and revenue

MCRB earnings per share for the last quarter are 0.58 USD whereas the estimation was -0.08 USD which accounts for 848.09% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 31.00 M USD. Estimated earnings per share for the next quarter are -0.20 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of MCRB earnings per share and revenue dynamics.